OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ITRM

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Iterum Therapeutics (ITRM) Earnings Date & Reports

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ITRM is expected to report earnings to fall 15.38% to -10 cents per share on November 07

Iterum Therapeutics ITRM Stock Earnings Reports

Q3'25

Est.

$-0.11

Q2'25

Missed

by $0.02

Q1'25

Beat

by $0.05

Q4'24

Beat

by $0.10

Q3'24

Missed

by $0.06

The last earnings report on August 05 showed earnings per share of -12 cents, missing the estimate of -10 cents. With 689.33K shares outstanding, the current market capitalization sits at 38.54M.

View a ticker or compare two or three

Compare

ITRM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ITRM
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ITRM showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Fitzwilliam Court

Phone

+353 16694820

Employees

Web

https://www.iterumtx.com